NOTV
Inotiv, Inc.NASDAQHealthcare$0.26-2.81%ClosedMarket Cap: $8.9M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.08
P/S
0.02
EV/EBITDA
21.40
DCF Value
$-90.38
FCF Yield
-322.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
18.1%
Operating Margin
-6.2%
Net Margin
-13.5%
ROE
-50.8%
ROA
-9.4%
ROIC
-4.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $120.9M | 9.1% | $-16.3M | $-28.4M | $-0.83 | — |
| Q4 2025 | $138.1M | 13.8% | $-6.8M | $-8.6M | $-0.25 | — |
| FY 2025 | $513.0M | 12.7% | $-30.9M | $-68.6M | $-2.11 | — |
| Q3 2025 | $130.7M | 26.0% | $-5.7M | $-17.6M | $-0.51 | — |
| Q2 2025 | $124.3M | 23.3% | $-2.9M | $-14.9M | $-0.44 | — |
| Q1 2025 | $119.9M | 20.9% | $-15.5M | $-27.6M | $-1.02 | — |
| Q4 2024 | $130.4M | 23.0% | $-13.2M | $-18.9M | $-0.73 | — |
| FY 2024 | $490.7M | 22.7% | $-86.4M | $-108.4M | $-4.19 | — |
| Q3 2024 | $105.8M | 19.9% | $-20.8M | $-26.1M | $-1.00 | — |
| Q2 2024 | $119.0M | 10.5% | $-40.4M | $-48.1M | $-1.86 | — |
| Q1 2024 | $135.5M | 14.2% | $-7.2M | $-15.4M | $-0.60 | — |
| Q4 2023 | $140.7M | 31.1% | $2.5M | $-9.7M | $-0.38 | — |